PLSH · Panacea Life Sciences Holdings, Inc. · Financials
$0.07
-0.01 (-14.71%)
At close · Sep 17
Going-concern doubt
— flagged May 6, 2024
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern for a period of 12 months from the issuance date of this report. Management cannot provide assurance that the Company will ultimately achieve profitable operations or become cash flow positive or raise additional debt and/or equity capital.”View the 10-Q filed May 6, 2024
Market Cap
$1.76M
Shares
17.65M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$2.38M
+3.7%
FY2023
Net Income
-$8.02M
+12.3%
FY2023
Gross Margin
47.04%
+29.8pp
FY2023
Operating Margin
-232.55%
+13.2pp
FY2023
Diluted EPS
-$0.48
+22.6%
FY2023
Operating Cash Flow
-$1.52M
+36.5%
FY2023
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| $2.76M | $2.38M | $2.3M | $2.06M | $9.02M | $345.68K | $0 | $0 | $0 | $213 | $852 | |
| $1.2M | $1.26M | $1.23M | $1.52M | $7.02M | $1.94M | $0 | — | — | — | — | |
| $1.56M | $1.12M | $396.47K | $540.58K | $2M | -$1.7M | $0 | — | — | — | — | |
| — | 47.04% | 17.24% | 26.25% | 22.15% | -491.92% | — | — | — | — | — | |
| — | — | — | — | $0 | $22.1K | $300K | $356.08K | $369.34K | $77.34K | $58.32K | |
| $383.84K | — | — | — | $638.63K | $948.3K | $18.04K | — | — | — | — | |
| $1.45M | $1.46M | $1.09M | $1.52M | $2.81M | $2.82M | $1.91M | $1.22M | $759.15K | $108.4K | $167.49K | |
| — | — | $61.4K | $61.4K | $61.4K | $828.53K | $0 | — | — | — | — | |
| — | — | — | — | — | — | $405.17K | $52.8K | $0 | $1627 | $1789 | |
| $6.88M | $6.67M | $6.05M | $6.48M | $7.26M | $8.97M | $2.44M | $3.12M | $1.6M | $389.28K | $421.11K | |
| -$5.31M | -$5.55M | -$5.65M | -$5.94M | -$5.26M | -$10.67M | -$2.44M | -$3.12M | -$1.6M | -$389.28K | -$420.26K | |
| — | -232.55% | -245.75% | -288.26% | -58.31% | -3087.46% | — | — | — | -182761.5% | -49326.06% | |
| — | — | — | — | — | — | -$2.03M | -$3.07M | -$1.6M | -$387.66K | -$418.47K | |
| $1.61M | $1.56M | $2.05M | $1.11M | $1.51M | $479.11K | $464.47K | $68.57K | $0 | — | — | |
| -$2.36M | -$2.47M | -$3.49M | $1.15M | $26.01K | $653.94K | -$1.9M | -$735.77K | -$1453 | $31.09K | $123.69K | |
| -$7.67M | -$8.02M | -$9.14M | -$4.78M | -$5.23M | -$10.02M | -$4.34M | -$3.86M | -$1.6M | -$358.19K | -$296.57K | |
| — | — | — | — | — | — | $0 | $0 | $0 | $0 | — | |
| -$7.67M | -$8.02M | -$9.14M | -$4.78M | -$5.23M | -$10.02M | -$4.34M | -$3.86M | -$1.6M | -$357.98K | -$296.57K | |
| — | -336.08% | -397.5% | -232.2% | -58.02% | -2898.29% | — | — | — | -168064.32% | -34808.8% | |
| -$13.73M | — | — | — | -$9.46M | -$10.39M | -$4.34M | — | — | — | — | |
| -$924.73K | — | — | — | — | — | — | — | — | -$357.98K | -$404.89K | |
| USD/shares | -$0.45 | -$0.48 | -$0.62 | -$0.28 | — | — | — | — | — | — | — |
| USD/shares | -$0.45 | -$0.48 | -$0.62 | — | — | — | — | — | — | — | — |
| shares | — | 16.63M | 14.86M | 16.92M | 16.92M | 33.9M | 4.76M | 4.24M | 19.22M | 512K | 13.07M |
| shares | — | 16.63M | 14.86M | 17.82M | 16.92M | 33.9M | 4.76M | 4.24M | 19.22M | 512K | 13.07M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Geography (USD)
| Component | FY2022 |
|---|---|
| Largo Florida | $2,900,000 |